Department of Radiation Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.
Department of Radiation Oncology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
Int J Radiat Oncol Biol Phys. 2015 Feb 1;91(2):419-26. doi: 10.1016/j.ijrobp.2014.10.022.
The Korean Radiation Oncology Group (KROG) 08-06 study protocol allowed radiation therapy (RT) technique to include or exclude breast cancer patients from receiving radiation therapy to the internal mammary lymph node (IMN). The purpose of this study was to assess dosimetric differences between the 2 groups and potential influence on clinical outcome by a dummy run procedure.
All participating institutions were asked to produce RT plans without irradiation (Arm 1) and with irradiation to the IMN (Arm 2) for 1 breast-conservation treatment case (breast-conserving surgery [BCS]) and 1 mastectomy case (modified radical mastectomy [MRM]) whose computed tomography images were provided. We assessed interinstitutional variations in IMN delineation and evaluated the dose-volume histograms of the IMN and normal organs. A reference IMN was delineated by an expert panel group based on the study guidelines. Also, we analyzed the potential influence of actual dose variation observed in this study on patient survival.
Although physicians intended to exclude the IMN within the RT field, the data showed almost 59.0% of the prescribed dose was delivered to the IMN in Arm 1. However, the mean doses covering the IMN in Arm 1 and Arm 2 were significantly different for both cases (P<.001). Due to the probability of overdose in Arm 1, the estimated gain in 7-year disease-free survival rate would be reduced from 10% to 7.9% for BCS cases and 7.1% for MRM cases. The radiation doses to the ipsilateral lung, heart, and coronary artery were lower in Arm 1 than in Arm 2.
Although this dummy run study indicated that a substantial dose was delivered to the IMN, even in the nonirradiation group, the dose differences between the 2 groups were statistically significant. However, this dosimetric profile should be studied further with actual patient samples and be taken into consideration when analyzing clinical outcomes according to IMN irradiation.
韩国放射肿瘤学组(KROG)08-06 研究方案允许放射治疗(RT)技术将乳腺癌患者纳入或排除接受内乳淋巴结(IMN)放射治疗。本研究的目的是通过模拟运行程序评估两组之间的剂量学差异以及对临床结果的潜在影响。
所有参与机构都被要求为提供的 CT 图像生成 1 例保乳治疗病例(保乳手术[BCS])和 1 例改良根治性乳房切除术(MRM)的 RT 计划,不进行照射(Arm 1)和照射到 IMN(Arm 2)。我们评估了 IMN 勾画的机构间差异,并评估了 IMN 和正常器官的剂量-体积直方图。一个专家小组根据研究指南勾画了参考 IMN。此外,我们还分析了本研究中观察到的实际剂量变化对患者生存的潜在影响。
尽管医生打算将 IMN 排除在 RT 野内,但数据显示,在 Arm 1 中,近 59.0%的规定剂量被输送到 IMN。然而,对于两种情况,Arm 1 和 Arm 2 中覆盖 IMN 的平均剂量差异显著(P<.001)。由于 Arm 1 中存在超量照射的可能性,BCS 病例的 7 年无病生存率估计增益将从 10%降低至 7.9%,MRM 病例的增益将从 7.1%降低至 7.9%。Arm 1 中的同侧肺、心脏和冠状动脉的辐射剂量低于 Arm 2。
尽管这项模拟运行研究表明,即使在非照射组中,IMN 也会受到大量剂量的照射,但两组之间的剂量差异具有统计学意义。然而,应该用实际的患者样本进一步研究这种剂量学特征,并在根据 IMN 照射分析临床结果时加以考虑。